Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003421313 | SCV004125129 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | RO60: BP4 |
Ambry Genetics | RCV004364483 | SCV005013482 | uncertain significance | not specified | 2021-10-06 | criteria provided, single submitter | clinical testing | The c.1030C>T (p.R344C) alteration is located in exon 5 (coding exon 4) of the TROVE2 gene. This alteration results from a C to T substitution at nucleotide position 1030, causing the arginine (R) at amino acid position 344 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |